We are live on ! Find out more
AUPH icon

Aurinia Pharmaceuticals
AUPH

191 hedge funds and large institutions have $498M invested in Aurinia Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 59 increasing their positions, 64 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

28% more call options, than puts

Call options by funds: $28.4M | Put options by funds: $22.1M

26% more capital invested

Capital invested by funds: $395M → $498M (+$103M)

3.15% more ownership

Funds ownership: 35.46% → 38.61% (+3.2%)

8% less repeat investments, than reductions

Existing positions increased: 59 | Existing positions reduced: 64

4% less funds holding

Funds holding: 198 → 191 (-7)

15% less first-time investments, than exits

New positions opened: 22 | Existing positions closed: 26

Holders
191
Holders Change
-7
Holders Change %
-3.54%
% of All Funds
2.78%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.01%
New
22
Increased
59
Reduced
64
Closed
26
Calls
$28.4M
Puts
$22.1M
Net Calls
+$6.26M
Net Calls Change
-$3.12M

Top Buyers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
+$28.7M
2
Morgan Stanley
Morgan Stanley
New York
+$12.2M
3
Schroder Investment Management Group
Schroder Investment Management Group
United Kingdom
+$8.57M
4
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$5.14M
5
Goldman Sachs
Goldman Sachs
New York
+$4.74M

Top Sellers

Rank Fund Capital Flow
1
AG
Artal Group
Luxembourg
-$7.77M
2
Renaissance Technologies
Renaissance Technologies
New York
-$4.35M
3
Two Sigma Investments
Two Sigma Investments
New York
-$3.74M
4
Two Sigma Advisers
Two Sigma Advisers
New York
-$3.57M
5
ECM
ExodusPoint Capital Management
New York
-$2.69M
Name Holding Trade Value Shares
Change 		Change in
Stake
State of Wisconsin Investment Board
26
State of Wisconsin Investment Board
Wisconsin
$2.44M +$1.37M +165,882 +158%
Swiss National Bank
27
Swiss National Bank
Switzerland
$2.41M -$249K -30,200 -10%
UBS Group
28
UBS Group
Switzerland
$2.28M +$505K +61,306 +32%
LFAS
29
Level Four Advisory Services
Texas
$2.13M -$126K -15,300 -6%
CCIA
30
Campbell & Co Investment Adviser
Maryland
$2.09M +$1.91M +232,411 New
6CM
31
683 Capital Management
New York
$1.98M +$1.81M +220,000 New
CS
32
Credit Suisse
Switzerland
$1.97M +$458K +55,597 +34%
JP Morgan Chase
33
JP Morgan Chase
New York
$1.97M -$77.5K -9,416 -4%
Barclays
34
Barclays
United Kingdom
$1.96M +$747K +90,719 +71%
Nordea Investment Management
35
Nordea Investment Management
Sweden
$1.86M -$91.4K -11,100 -5%
Simplex Trading
36
Simplex Trading
Illinois
$1.84M -$141K -17,091 -8%
JAM
37
Jupiter Asset Management
United Kingdom
$1.83M +$1.42M +172,411 +551%
SS
38
Sunbelt Securities
Texas
$1.73M -$29.2K -3,540 -2%
ASN
39
Advisory Services Network
Georgia
$1.7M -$6.31K -766 -0.4%
RhumbLine Advisers
40
RhumbLine Advisers
Massachusetts
$1.63M +$5.47K +664 +0.4%
Two Sigma Investments
41
Two Sigma Investments
New York
$1.56M -$3.74M -454,720 -72%
Wells Fargo
42
Wells Fargo
California
$1.45M -$245K -29,724 -16%
UBS AM
43
UBS AM
Illinois
$1.44M +$103K +12,447 +8%
Two Sigma Advisers
44
Two Sigma Advisers
New York
$1.35M -$3.57M -433,000 -74%
CF
45
Cantor Fitzgerald
New York
$1.31M +$369K +44,855 +45%
Invesco
46
Invesco
Georgia
$1.3M +$80.3K +9,751 +7%
California State Teachers Retirement System (CalSTRS)
47
California State Teachers Retirement System (CalSTRS)
California
$1.29M -$53K -6,431 -4%
AllianceBernstein
48
AllianceBernstein
Tennessee
$1.22M – – –
Parallax Volatility Advisers
49
Parallax Volatility Advisers
California
$1.22M -$238K -28,858 -18%
Renaissance Technologies
50
Renaissance Technologies
New York
$1.21M -$4.35M -528,000 -80%
1
2
3 4 5

AUPH Hedge Fund Activity: Q4 2023 in Review

191 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Aurinia Pharmaceuticals (AUPH) for Q4 2023, worth a combined $498M — up 26% from $395M a quarter earlier.

Sellers outnumbered buyers: 26 funds closed out of AUPH and 22 opened new positions — a net loss of 4 holders — while 64 trimmed existing stakes and 59 added.

The largest buyer was Armistice Capital, adding an estimated $28.7M. The largest seller was Artal Group, exiting entirely with an estimated $7.77M sold.

  • 191 institutional investors held Aurinia Pharmaceuticals (AUPH) as of Q4 2023, down from 198 in Q3 2023.
  • Funds reported $498M of Aurinia Pharmaceuticals stock for Q4 2023, up 26% quarter-over-quarter.
  • 22 funds opened new Aurinia Pharmaceuticals positions in Q4 2023 and 26 closed out, a net change of -4 holders.
  • The largest Aurinia Pharmaceuticals buyer in Q4 2023 was Armistice Capital, an estimated $28.7M added.
  • The largest Aurinia Pharmaceuticals seller in Q4 2023 was Artal Group, an estimated $7.77M sold.

Based on aggregated 13F filings for Q4 2023.